Bacitracin: an inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of the peptidoglycan of bacterial cell walls.

doi:10.1073/PNAS.57.3.767

Paper

Bacitracin: an inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of the peptidoglycan of bacterial cell walls.

Published Mar 1, 1967 · G. Siewert, J. Strominger

Proceedings of the National Academy of Sciences of the United States of America

Q1 SJR score

221

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Bacitraciin is a polypeptide antibiotic produced by certain strainis of Bacillus licheniformis. It inhibits bacterial cell wall synthesis and induces the accumulation in Staphylococcus aureus of UDP-acetylmuramyl-pentapeptide,I a precursor of the cell wall. Recent studies of the detailed mechanism of biosynthesis of the peptidoglycaii of bacterial cell walls have revealed a process that occurs in three stages, viz.: (1) biosynthesis of the uridinie nucleotide precursors, (2) utilization of these precursors to form linear peptidoglycari strands, and (3) cross-linking of the liinearstrands.2 Each of these stages is specifically inhibited by different anti.biotics. Ristocetin, vancomycin, and bacitracin are all inhibitors of the second stage.3 This stage is a complex reaction sequence which occurs in the cell membralle as a consequence of which the sugar fragments of the uridine nucleotide precursors become attached to a phospholipid carrier in the membrane and are then modified. Studies of the individual reactions in this cycle (Fig. 1) have revealed that the re

Highly Cited

Study Snapshot

Bacitracin inhibits the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of bacterial cell wall peptidoglycan.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Paper

Bacitracin: an inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of the peptidoglycan of bacterial cell walls.

References

Citations

Advances in the discovery, mechanism of action, optimization of activity and potential for clinical application of antimicrobial peptides

Advances in molecular design, modification, and optimization strategies have enhanced the biological and chemical properties of antimicrobial peptides, potentially offering more effective alternatives to antibiotics.

Investigating Aerobic Hive Microflora: Role of Surface Microbiome of Apis Mellifera

Surface microbes on honeybees may play a protective role against diseases, but their origin and role remain unclear.

Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity

Guanidino lipoglycopeptides show potent antibacterial activity and improved safety profiles compared to vancomycin, making them potential candidates for treating multidrug-resistant Gram-positive infections.

A Novel Bacitracin-like Peptide from Mangrove-Isolated Bacillus paralicheniformis NNS4-3 against MRSA and Its Genomic Insights

Bacillus paralicheniformis NNS4-3, a mangrove microbe, exhibits significant activity against methicillin-resistant Staphylococcus aureus (MRSA) and its bacitracin-like peptide shows potential in combating antimicrobial resistance.

A classic antibiotic reimagined: Rationally designed bacitracin variants exhibit potent activity against vancomycin-resistant pathogens

Bacitracin variants designed with crystallographic insights show enhanced antibacterial activity against vancomycin-resistant pathogens, contributing to the revitalization of our antibiotics arsenal.